Zusammenfassung
Als Karzinoide (Oberndorfer 1907) bezeichnet man epitheliale, häufig hor-monaktive Tumoren, die sich von den Zellen des diffusen, endokrinen Systems in den Organen des embryonalen Darmrohrs vom Kiemen- bis zum Enddarm (Williams U. Sandler 1963) aber auch im Urogenitaltrakt ableiten (Williams et al. 1980). Da diese Tumoren ein unterschiedliches Spektrum endokriner oder biochemischer Aktivität aufweisen, ist der Begriff Karzinoid im wesentlichen morphologisch charakterisiert (Soga 1976). Er wird durch histochemische, biochemische und immunhistologische Methoden weiter präzisiert.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Allison D, Modlin IM, Jenkins WJ (1977) Treatment of carcinoid liver metastases by hepatic artery embolization. Lancet II: 1323–1325
Alumets J, Hakanson R, Ingemansson S, Sundler F (1977) Substance P and 5-HT in granules isolated from intestinal argentaffin carcinoid. Histochemistry 52: 217–222
Alumets J, Ekelund G, Hakanson R, Ljungberg O, Ljungqvist U, Sundler F, Tibblin S (1978) Jejunal endocrine tumour composed of somatostatin and gastrin cells and associated with duodenal ulcer disease. Virchow Arch A Pathol Anat Histol 378: 17–22
Anthony PP (1970) Gangrene of the small intestine - a complication of argentaffin carcinoma. Br J Surg 57: 118–122
Anthony PP, Drury RAB (1970) Elastic vascular sclerosis of mesenteric blood vessels in argentaffin carcinoma. J Clin Pathol 23: 110–118
Antonson S, Hansen MGJ, Burkhave K, Rask-Madsen J (1982) Influence of a new selective 5-HT2 receptor antagonist (ketanserin) on jejunal PGE2 release and ion secretion due to malignant carcinoid syndrome. Gut 23: A884
Axelson S, Björklund A, Falck B, Lindvall O, Svensson LA (1973) Glyoxylic acid condensation: A new fluorescence method for the histochemical demonstration of biogenic monoamines. Acta Physiol Scand 87: 57–62
Baca I, Junghanns KH, Feurle GE, Hoevels J (1982) Gastrinom der Duodenalwand. Akt Chir 17: 125–126
Barclay GPT, Robb WAT (1968) A clinicopathologic study of carcinoid tumors. Surg Gynecol Obstet 126: 483–496
Barter R, Pearse AGE (1953) Detection of 5-hydroxytryptamine in mammalian enterochromaffin cells. Nature 172: 810
Becker V, Kümmerle F, Schlier J, Lenner V, Londong W (1976) Tumoren des endokrinen Pankreas. In: Forell MM (Hrsg) Handbuch der inneren Medizin III, Teil 6. S 1042–1104
Bennett A, Eley KG, Scholes GB (1968) Effects of prostaglandins Ex and E2 on human guinea-pig and rat isolated small intestine. Br J Pharmacol 34: 630–638
Bhoola KD, Collier HOJ, Schachter M, Shorley PG (1962) Actions of some peptides on bronchial muscle. Br J Pharmacol 19: 190–197
Bisset GW, Lewis GP (1962) A spectrum of pharmacological activity in some biologically active peptides. Br J Pharmacol 19: 168–182
Bivens CH, Marecek RL, Feldmann JM (1973) Peyronie’s disease - a presenting complaint of the carcinoid syndrome. N Engl J Med 289: 844–845
Björklund A, Falck B, Hakansson R (1968) Histochemical demonstration of tryptamine. Properties of the formaldehyde-induced fluorophores of tryptamine and related indole compounds in models. Acta Physiol Scand [Suppl] 318: 1–31
Black WC III (1968) Enterochromaffin cell types and corresponding carcinoid tumors. Lab Invest 19: 473–486
Büchler MW (1981) Strukturanalyse des Meckelschen Divertikels unter besonderer Berücksichtigung der endokrinen Zellen. In: Doerr W, Leonhardt H (Hrsg) Normale und pathologische Anatomie. Thieme, Stuttgart New York
Bukhave K, Rask-Madsen J (1979) Prostaglandins and chronic diarrhoea: Methodological problems. Scand J Gastroenterol [Suppl 53] 14: 67–71
Bukhave K, Rask-Madsen J (1980) Saturation kinetics applied to in vitro effects of low prostaglandin E2 and F2 concentrations onion transport across human jejunal mucosa. Gastroenterology 78: 32–42
Carter SK, Broder LE (1974) The cytostatic therapy of hormone-secreting tumours of the gastrointestinal tract. Clin Gastroenterol 3: 733–745
Casella C, Reggiani M (1946) Spettro di fluorescenza delle cellule enterochromaffini di cavia. Boll Soc Ital Biol Sper 22: 480–481
Cassidy MA (1931) Abdominal carcinomatosis with probable adrenal involvement. Proc Roy Soc Med 24: 139–141
Collatz Christensen S, Stage JG, Henriksen FW (1979) Angiography in the diagnosis of carcinoid syndrome. Scand J Gastroenterol [Suppl 53] 14: 111–114
Comroe JH, Van Lingen B, Stroud RC, Roncoroni A (1953) Reflex and direct cardiopulmonary effects of 5-OH-tryptamine (serotonin). Their possible role in pulmonary embolism and coronary thrombosis. Am J Physiol 173: 379–384
Coons AH, Leduc EH, Conolly JM (1955) Studies on antibody production. 1. A method for the histochemical demonstration of specific antibody and its application to a study of the hyperimmune rabbit. J Exp Med 102: 49–60
Corrodi H, Jonsson G (1967) The formaldehyde fluorescence method for the histochemical demonstration of biogenic monoamines. A review on the methodology. J Histochem Cytochem 15: 67–78
Creutzfeldt W, Arnold R, Creutzfeldt C, Track NS (1975) Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas ( Zollinger-Ellison syndrome ). Hum Pathol 6: 47–76
Cuello AC, Wells C, Chaplin AJ, Milstein C (1982) Serotonin immunoreactivity in carcinoid tumours demonstrated by a monoclonal antibody. Lancet 1: 771–773
Damgaard-Petersen K, Stage JG (1979) CT Scanning in Patients with Zollinger-Ellison Syndrome and Carcinoid Syndrome. Scand J Gastroenterol [Suppl 53] 14: 117–122
Davis Z, Moertel CG, Mcllrath DC (1973) The malignant carcinoid syndrome. Surg Gynecol Obstet 137: 637–644
Degkwitz R, Frowein R, Kirberger E, Kuhlenkampff C, Mohs U (1962) Über Normalwerte der stündlichen 5-HIES-Ausscheidung im Urin beim Menschen und die Messungen störende Faktoren. Klin Wochenschr 40: 285–289
Dery R (1971) Theoretical and clinical considerations in anaesthesia for secreting carcinoid tumors.Can Anaesthet Soc 18: 245–263
Dharmsathaphorn K, Sherwin RS, Cataland S, Jaffe B, Dobbins J (1980) Somatostatin inhibits diarrhea in the carcinoid syndrome. Ann Intern Med 92: 68–69
Diffenbaugh WG, Anderson RE (1956) Carcinoid (argentaffin) tumors of the gastrointestinal tract. Arch Surg 73: 21–37
Duner H, Pernow B (1960). Circulatory studies on substance P in man. Acta Physiol Scand 49: 261–266
Ehinger B, Thunberg R (1967) Induction of fluorescence in histamine-containing-cells. Exp Cell Res 47: 116–122
Engelman K, Lovenberg W, Sjoerdsma A (1967) Inhibition of serotonin synthesis by para-chlorophe-nylalanine in patients with the carcinoid syndrome. N Engl J Med 277:1103–1108 Eränkö O (1951) On the histochemistry of the rat adrenal medulla. Acta Physiol Scand [Suppl 89] 25: 22–23
Erspamer V, Asero B (1952) Identification of enteramine, the spezific hormone of the enterochromaf-fine cell system, as 5-hydroxy-tryptamine. Nature 169: 800–801
Eschbach JW, Rinaldo JA (1962) Metastatic carcinoid: A familial occurrence. Ann Intern Med 57: 647–650
Falck B (1962) Observations on possibilities of the cellular localisation of monoamines by a fluorescence method. Acta Physiol Scand 56 Supp 197: 1–25
Feldman JM (1978) Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxy-tryptophan-secreting tumors. Gastroenterology 75: 1109–1114
Feurle GE, Helmstädter V, Hoevels J, Wenzel-Herzer E, Klempa I (1982) Wandel von Diagnose und Therapie beim Zollinger-Ellison-Syndrom. Dtsch Med Wochenschr 107: 697–704
Feyrter F (1932) Carcinoid und Carcinom. Ergeb Pathol 29: 305–489
Feyrter F (1953) Uber die peripheren endokrinen (parakrinen) Drüsen des Menschen. Maudrich, Wien Düsseldorf
Feyrter F (1962) Über die peripheren endokrinen (parakrinen) Drüsen und ihre Geschwülste, insbesondere das enterale und das bronchiale Karzinoid. Verh Dtsch Ges Inn Med 68: 161–182
Fleischmajer R, Hyman AB (1961) Clinical significance of derangements of tryptophan metabolism. Arch Dermatol 84: 563–573
Fröhlich JC, Bloomgarden ZT, Oates JA, McGuigan JE, Rabinowitz D (1978) The carcinoid flush Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med 299: 1055–1057
Funk HU, Hardmeier T, Hedinger C (1965) Zur Beurteilung der Dignität intestinaler Carcinoide. Z Krebsforsch 67: 278–288
Gamse R, Saria A, Bucsics A, Lembeck F (1981) Substance P in tumors: pheochromocytoma and carcinoid. Peptides [Suppl 2] 2: 275–280
Ganda OP, Weir GC, Soeldner JS, Legg MA, Chick WL, Patel YC, Ebeid AM, Gabbay KH, Reichlin S (1977) „Somatostatinoma“A Somatostatin-containing tumor of the endocrine pancreas. N Engl J Med 296: 963–967
Geffroy Y, Laumonier R, Matray F (1967) Les tumeurs carcinoides de l’intestine grele. Rev Prat (Paris) 17: 727–745
Godwin JD (1975) Carcinoid tumors. An Analysis of 2837 cases. Cancer 36: 560–569
Goedert M, Otten U, Suda K, Heitz PU, Stalder GA, Obrecht JP, Holzach P, Allgöwer M (1980) Dopamine, norepinephrine and serotonin production by an intestinal carcinoid tumor. Cancer 45: 104–107
Gösset A, Masson P (1914) Tumeurs endocrines de l’appendice. Presse Med 22: 237–240
Grahame-Smith DG (1964) Tryptophan hydroxylation in carcinoid tumors. Biochem Biophys Acta 86: 176–179
Grahame-Smith DG (1972) The carcinoid syndrome. Heinemann London Green D, Joynt RJ, van Allen MV (1964) Neuromyopathy associated with a malignant carcinoid tumor. Arch Intern Med 114: 494–496
Grimelius L (1968) A silver nitrate stain for a2-cells in human pancreatic islets. Acta Soc Med Uppsal 73: 243–276
Grimelius L (1969) An electron microscopic study of silver stained adult human pancreatic islet cells, with reference to a new silver nitrate procedure. Acta Soc Med Uppsal 74: 28–48
Hakanson R, Bengmark S, Brodin E, Ingemansson S, Larsson LI, Nilsson G, Sundler F (1977) Substance P-like immunoreactivity in intestinal carcinoid tumors. In: Euler US, Pernow B (eds) Substance P. Raven, New York, pp 55–58
Hales CA, Mark EJ (1981) Exertional dyspnoea, cough, and hepatomegaly in a 58 year old man. N Engl J Med 304: 1350–1356
Hamperl H (1932) Was sind argentaffine Zellen? Virchows Arch Pathol Anat 286: 811–833
Hanna SM (1965) Carcinoid syndrome associated with psychosis. Postgrad Med J 41: 566–567
Hedinger C (1959) Karzinoidsyndrom. Schweiz Med Wochenschr 52:1362–1364 Hedinger C (1972) Karzinoide des Verdauungstrakts. Helv Chir Acta 40: 701–713
Hegglin R, Zollinger H (1956) Klinisch-pathologisch-anatomische Demonstrationen ( Mitralstenose, Libman-Sacks-Syndrom und metastasierendes Dünndarmkarzinoid). Cardiologia 28: 151–167
Heidenhain R (1870) Untersuchungen über den Bau der Labdrüsen. Arch Mikroskop Anat 6: 368 – 406
Heitz P, Polak JM, Timson CM, Pearse AGE (1976) Enterochromaffin cells as the endocrine source of gastrointestinal substance. P. Histochemistry 49: 343–347
Herkheimer H (1953) Further observations on the influence of 5-hydroxytryptamine on bronchial function. J Physiol (Lond) 122: 49P–50 P
Höfler H, Auböck L, Ratzenhofer M (1982) Neurogene Appendicopathie - eine facultative Vorerkrankung des Appendixcarcinoids. In: Doerr W, Leonhardt H (Hrsg) Normale und pathologische Anatomie, vol 45. Thieme, Stuttgart New York
Hofmann JW, Fox PS, Wilson SD (1973) Duodenal wall tumors and the Zollinger-Ellison syndrome. Arch Surg 107: 334–339
Horton EW, Main IHM, Thompson CJ, Wright PM (1968) Effect of orally administered Prostaglan¬din Ex on gastric secretion and gastrointestinal motility in man. Gut 9: 655–658
Huebschmann P (1910) Sur le carcinome primitif de l’appendice vermiculaire. Rev Med Suisse Rom 30: 317–332
Hui K, Reza MJ, Busuttil RW (1978) An unusual cause of massive gastrointestinal hemorrhage. JAMA 239: 2690–2691
Hunt RH, Dilawari JB, Misiewicz JJ (1975) The effect of intravenous prostaglandins F2a and E2 on the motility of the sigmoid colon. Gut 16: 47–49
Ingemansson S, Larsson LI, Lunderqvist A, Stadil F (1977) Pancreatic vein catheterization with gastrin assay in normal patients and in patients with the Zollinger-Ellison syndrome. Am J Surg 134: 558–563
Isler P, Hedinger C (1953) Metastasierendes Dünndarmcarcinoid mit schweren, vorwiegend das rechte Herz betreffenden Klappenfehlern und Pulmonalstenose - ein eigenartiger Symptomenkomplex? Schweiz Med Wochenschr 83: 4–7
Jaffe BM (1979) Prostaglandins and serotonin: Nonpeptide diarrheogenic hormones. World J Surg 3: 565–577
Jaffe BM, Condon S (1976) Prostaglandins E and F in endocrine diarrheagenic syndromes. Ann Surg 184: 516–524
Jepson JB (1955) Paper chromatography of urinary indoles. Lancet 11: 1009–1011
Jouanneau P, Malafosse M (1971) Le tumeurs carcinoides du tube digestif. Masson, Paris
Kähler HJ (1967) Das Karzinoid. Springer, Berlin Heidelberg New York
Kähler HJ (1968) Laboratoriumsbefunde beim Karzinoidsyndrom. Dtsch Med Wochenschr 93: 959–961
Kähler HJ, Heilmeyer L (1961) Klinik und Pathophysiologic des Karzinoids und Karzinoidsyndroms unter besonderer Berücksichtigung der Pharmakologie des 5-Hydroxytryptamins. Ergeb Inn Med Kinderheilk 16: 291–559
Kaneko H, Yanaihara N, Ito S, Kusumoto Y, Fujita T, Ishikawa S, Sumida T, Sekiya M (1979) Somatostatinoma of the duodenum. Cancer 44: 2273–2279
Kaude JV (1973) Calcification of carcinoid tumors. N Engl J Med 289: 921
Kisloff B, Moore EW (1976) Effect of serotonin on water and electrolyte transport in vivo rabbit small intestine. Gastroenterology 71: 1033–1038
Kowlessar OD, Law DH, Sleisenger MH (1959) Malabsorption syndrome associated with metastaticcarcinoid tumor. Am J Med 27:673–677
Kultschitzky N (1897) Zur Frage über den Bau des Darmkanals. Arch Mikroskop Anat 49: 7–35
Lachapelle JM, Philippart JL, Tennstedt D, Balthazar E (1977) Syndrome carcinoide: Manifestations cutanées chroniques florides. Ann Derm Vénéréol (Paris) 104: 66–67
Lanfranchi J, Morand P, Groussien P (1972) Le cardiopathies carcinoides. Ann Cardiol Angiol 21: 183–192
Langhans T (1867) Über einen Drüsenpolyp im Ileum. Arch Pathol Anat 38: 559–560
Larsson LI, Hirsch MA, Holst JJ, Ingemansson S, Kühl C, Jensen SL, Lundqvist G, Rehfeld JF, Schwartz TW (1977) Pancreatic Somatostatinoma. Clinical features and physiological implications. Lancet 1: 666–668
Legha SS, Valdivieso M, Nelson RS, Benjamin RS, Bodey GP (1977) Chemotherapy for metastatic carcinoid tumors: Experiences with 32 patients and review of the literature. Cancer Treat Rep 61: 1699–1703
Lembeck F (1953) 5-hydroxytryptamine in a carcinoid tumor. Nature (London) 172:910–911
Lembeck F (1962) Biochemie und Pharmakologie der Carzinoide. Verh Dtsch Ges Med 68:194–211 Levine RJ, Sjoerdsma A (1963) Pressor amines and the carcinoid flush. Ann Intern Med 58: 818–828
Liljedahl SO, Mattsson O and Pernow B (1958) Effect of substance P on intestinal motility in man. Scand J Clin Lab Invest 10: 16–25
Linell F, Mansson K (1966) On the prevalence and incidence of carcinoids in Malmö. Acta Med Scand [Suppl] 445: 377–382
Long RG, Peters JR, Bloom SR, Brown MR, Vale W, Rivier JE, Grahame-Smith DG (1981) Somatostatin, gastrointestinal peptides, and the carcinoid syndrome. Gut 22: 549–553
Lubarsch O (1888) Über den primären Krebs des Ileum nebst Bemerkungen über das gleichzeitige Vorkommen von Krebs und Tuberkulose. Arch Pathol Anat 111: 280–317
Lunderquist A, Ericsson M, Nobin A, Sandén G (1982) Gelfoam powder emolization of the hepatic artery in liver metastases of carcinoid tumors. Radiologe 22: 65–70
Lundqvist M, Wilander E (1981) Somatostatin-like immunoreactivity in mid-gut carcinoids. Acta Path Microbiol Scand Sect A 89: 335–337
Luse SA, Lacy PE (1960) Electron microscopy of a malignant argentaffin tumor. Cancer 13: 334–346
McCarthy DM (1980) The place of surgery in the Zollinger-Ellison syndrome. N Engl J Med 302: 1344–1347
MacDonald RA (1956) A study of 365 carcinoids of the gastrointestinal tract. Am J Med 21: 867–878
McKusick VA (1956) Carcinoid cardiovascular disease. Bull Johns Hopkins Hosp 98: 13–36
Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B (1974) A glucagonoma syndrome. Lancet II: 1–5
Marks C (1979) Carcinoid tumors. Hall, Boston, Mass. USA
Martin RG (1970) Management of carcinoid tumors. Cancer 26: 547–551
Mason RA, Steane PA (1976) Carcinoid syndrome: its relevance to the anesthetist. Anesthesia 31: 228–242
Matuchansky C, Bernies JJ (1973) Effect of prostaglandin Et on glucose, water, and electrolyte absorption in the human jejunum. Gastroenterology 64: 1111–1118
Melmon K, Lovenberg W, Sjoerdsma A (1965a) Identification of lysyl-bradykinin as the peptide formed in vitro by carcinoid tumour kallikrein. Clin Chem Acta 12: 292–297
Melmon KL, Sjoerdsma A, Oates JA, Laster L (1965) Treatment of malabsorption and diarrhea of the carcinoid syndrome with methysergide. Gastroenterology 48: 18–24
Mengel CE (1963) Cutaneous manifestations of the malignant carcinoid syndrome. Ann Intern Med 58: 989–993
Mengel CE (1965) Therapy of the malignant carcinoid syndrome. Ann Intern Med 62: 587–602
Mengel CE, Lotito CA (1968) A new antiserotonin in the carcinoid syndrome. Arch Intern Med 121: 507–510
Methfessel HD, Bettziesche H, Methfessel G (1973) Schwangerschaft und Geburt bei Appendixkarzi-noid mit familiärer Disposition. Zbl Gynaekol 95: 234–238
Meves M, Abdelhamid S, Wollenweber J (1982) Die Embolisation der Arteria hepatica zur Behandlung des Karzinoid-Syndroms. Z Gastroenterologie 20: 438–447
Misiewicz JJ, Waller SL, Eisner M (1966) Motor responses of human gastrointestinal tract to 5-hydroxytryptamine in vivo and in vitro. Gut 7: 208–216
Misiewicz JJ, Waller SL, Kiley N, Horton EW (1969) Effect of oral prostaglandin Ei on intestinal transit time in man. Lancet 1: 648–651
Moertel CG, Sauer WG, Dockerty MB, Baggenstoss AH (1961) Life history of the carcinoid tumor of the small intestine. Cancer 14: 901–912
Mustala O.O., Tuomisto JJ, Airaksinen MM (1964) A new modification for the determination of 5-hydroxyindole-acetic acid (5-HIAA) in urine. Scand J Clin Lab Invest 16: 655–660
Nash DT, Brin M (1964) Malabsorption in malignant carcinoid with normal 5 HIAA. NY St J Med 64: 1128–1131
Oates JA, Butler TC (1967) Pharmacologic and endocrine aspects of carcinoid syndrome. Adv Pharmacol 5: 109–128
Oates JA, Sjoerdsma A (1962) A unique syndrome associated with secretion of 5-hydroxytryptophan by metastatic gastric carcinoids. Am J Med 32: 333–342
Oates JA, Melmon K, Sjoerdsma A, Gillespie L, Mason DT (1964) Release of a kinin peptide in the carcinoid syndrome. Lancet 1: 514–517
Oates JA, Pettinger WA und Doctor RB (1966) Evidence for the release of bradykinin in carcinoid syndrome. J Clin Invest 45: 173–178
Oberndorfer S (1907) Karzinoide Tumoren des Dünndarms. Frankf Z Pathol 1: 426–432
Otten MH, Birkenhaeger JC, van Blankenstein M (1978) Zollinger-Ellison syndrome treated by endoscopical removal of a duodenal gastrinoma. Neth J Med 21: 248–251
Pearse AGE (1972) Histochemistry. Theoretical and applied, vol II, 3rd ed. Churchill Livingstone, Edinburgh London
Pearse AGE, Polak JM (1975) Immunocytochemical localization of substance P in mammalian intestine. Histochemistry 41: 373–375
Peavy PW, Rogers JV, Clements JL, Burns JB (1973) Unusual osteoplastic metastases from carcinoid tumors. Radiology 107: 327–330
Peiper HJ, Creutzfeldt W (1975) Endokrine Tumoren des Gastrointestinaltraktes. Chirurg 46: 194–203
Pernow B, Waldenstrom J (1954) Paroxysmal flushing and other symptoms caused by 5 hydroxytrypt-amine and histamine in patients with malignant tumours. Lancet 11: 951
Pernow B, Waldenstrom J (1957) Determination of 5-hydroxytryptamine, 5-hydroxy-indole acetic acid and histamine in thirty three cases of carcinoid tumors (argentaffinoma). Am J Med 23: 16–25
Plonk JW, Feldmann JM (1974) Carcinoid arthropathy. Arch Intern Med 134: 651–654
Portela-Gomes GM (1982) Enterochromaffin cells. A qualitative and quantitative study. University of Uppsala
Rask-Madsen J and Bukhave K (1979) Prostaglandins and chronic diarrhoea: Clinical aspects. Scand J Gastroenterol [Suppl 53] 14: 73–78
Reichardt W (1978) Angiographischer Befund bei Karzinoidmetastasen im Mesenterium. Fortschr Röntgenstr 129: 185–188
Roberts WC, Sjoerdsma A (1964) The cardiac disease associated with the carcinoid syndrome (carcinoid heart disease). Am J Med 36: 5–34
Robertson JIS, Peart WS, Andrews TM (1962) The mechanism of facial flushes in the carcinoid syndrome. Q J Med 31: 103–123
Roggli VL, Judge DM, McGavran MH (1979) Duodenal glucagonoma: A case report. Hum Pathol 10: 350–353
Rosenbaum FF, Santer DG, Claudon DB (1953) Essential teleangiectasia, pulmonic and tricuspid stenosis, and neoplastic liver disease. A possible new clinical syndrome. J Lab Clin Med 42: 941–942
Said SI and Mutt V (1977) Relationship of spasmogenic and smooth muscle relaxant peptides from normal lung to other vasoactive peptides. Nature 265: 84–86
Sanders RJ (1973) Carcinoids of the gastrointestinal tract. Thomas, Springfield USA
Sandler M, Snow PDJ (1958) An atypical carcinoid tumor secreting 5-hydroxytryptophan. Lancet 1: 137–140
Schauer A, Eder M (1959) Der Fibrosierungsvorgang beim Darmcarcinoid. Klin Wochenschr 37: 880–881
Schmidt JE (1905) Beiträge zur normalen und pathologischen Histologie einiger Zellarten der Schleimhaut des menschlichen Darmkanals. Arch Mikr Anat 66: 12–40
Schön H, Ordnung W, Schmid E (1960) Zum Nachweis der 5-Hydroxyindolessigsäure im Harn. Klin Wochenschr 38: 405–406
Schölte AJ (1931) Ein Fall von Angioma teleangiectaticum cutis mit chronischer Endocarditis und malignem Dünndarmcarcinoid. Beitr Pathol Anat 86: 440–443
Schuhmacher A, Schulz H (1963) Licht- und elektronenmikroskopische Untersuchungen an einem metastasierenden Dünndarmcarcinoid mit Serotoninbestimmungen an Tumorzellfraktionen. Klin Wochenschr 41: 1188–1196
Schweizer W, Gloor F, von Bertrap R, Dubach UC (1964) Carcinoid heart disease with left-sided lesions. Circulation 29: 253–257
Serratoni FT, Robboy SJ (1975) Ultrastructure of primary and metastatic ovarian carcinoids: Analysis of 11 cases. Cancer 36: 157–160
Sherman SP, Li C-Y, Carney JA (1979) Microproliferation of enterochromaffin cells and the origin of carcinoid tumors of the ileum. Arch Pathol Lab Med 103: 639–641
Sjoerdsma A, Weissbach H, Udenfriend S (1955) Simple test for diagnosis of metastatic carcinoid ( Argentaffinoma ). JAMA 159: 397
Sjoerdsma A, Weissbach H, Terry LL, Udenfriend S (1957) Further observations on patients with malignant carcinoid. Am J Med 23: 5–15
Sjoerdsma A, Lovenberg W, Engelman K, Carpenter WT, Wyatt RJ, Gessa GL (1970) Serotonin now: Clinical implications of inhibiting its synthesis with para chlorophenylalanine. Ann Intern Med 73: 607–629
Skrabanek P, Cannon D, Kirrane J, Powell D (1978) Substance P secretion by carcinoid tumours. Ir J Med Sci 147: 47–49
Soga J (1976) Neoplasms of the GEP endocrine cells: The present-day concept of carcinoids. In: Fujita T (ed) Endocrine gut and pancreas. Elsevier, Amsterdam, pp 387–394
Soga J, Tazawa K (1971) Pathologic analysis of carcinoids. Cancer 28: 990–998
Solcia E, Capella C, Buffa R, Frigerio B (1976) Histochemical and ultrastructural studies on the argentaffin and argyrophil cells of the gut. In: Coupland RE, Fujita T (eds) Chromaffin, enterochromaffin and related cells. Elsevier Scientific Publishing Company, Amsterdam Oxford New York, pp 209–225
Solcia E, Buffa R, Crivelli O, Yanaihara N, Polak JM (1981a) Immunohistochemistry of gastric releasing peptide (GRP) and 5-hydroxytryptamine (5 HT) in the gut neuroendocrine systeme. International Symposion on Brain-Gut Axis, Florenz, 1981 [Abstr], p 168
Solcia E, Capella C, Buffa R, Usellini L, Fiocca R, Frigerio B, Tenti P, Sessa F (1981b) The diffuse endocine-paracrine system of the gut in health and disease: Ultrastructural features. Scand J Gastroenterol [Suppl 70] 14: 25–36
Stahl SM, Levin B (1982) Serotonin depletion by fenfluramine in the carcinoid syndrome. N Engl J Med 306: 429
Steger C, Sarra A (1960) Zur Entstehung der beim metastasierenden Dünndarmkarzinoid beobachteten Klappen Veränderungen des rechten Herzens. Helv Chir Acta 27: 15–29
Steger C, Sette B (1964) Über die pathogenetische Bedeutung des 5-Hydroxytryptamins in der Entstehung der Klappen Veränderungen des rechten Herzens bei Karzinoidträgern. Helv Chir Acta 31: 353–363
Sternberger LA (1974) Immunocytochemistry Englewood Cliffs. Prentice-Hall, New Jersey Swain CP, Tavill AS, Neale G (1976) Studies of tryptophan and albumin metabolism in a patient with carcinoid syndrome, pellagra, and hypoproteinemia. Gastroenterology 71: 484–489
Thorson A, Biörck G, Björkman G, Waldenstrom J (1954) Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis. A clinical and pathologic syndrome. Am Heart J 47: 795–817
Thulin L, Samnegard H, Tyden G, Long DH, Efendic S (1978) Efficacy of somatostatin in a patient with carcinoid syndrome. Lancet II: 43 Udenfriend S, Weissbach H, Clark CT (1955) The estimation of 5-hydroxytryptamin (serotonin) in biological tissues. J Biol Chem 215: 337–344
Vassallo G, Capella C, Solcia E (1971) Grimelius silver stain for endocrine cell granules, as shown by electron microscopy. Stain Technol 46: 7–13
Verley JM (1965) Les tumeurs carcinoides bronchiques et digestives de l’homme. Z Krebsforsch 66: 503–516
Waldenstrom J, Pernow B, Silver H (1956) Case of metastasizing carcinoma (argentaffinoma?) of unknown origin showing peculiar red flushing and increased amounts of histamine and 5-hydroxytryptamine in blood and urine. Acta Med Scand 156: 73–83
Weichert R, Reed R, Creech O (1967) Carcinoid-islet cell tumors of the duodenum. Ann Surg 5: 660–669
Weidner FA, Ziter FMH (1981) Carcinoid tumors of the gastrointestinal tract. JAMA 245: 1153–1155
Wilander E, El-Salhy M (1981) Immuno-cyto-chemical staining of mid-gut carcinoid tumours with sequence-specific gastrin antisera. Acta Pathol Microbiol Scand Sect A 89: 247–250
Wilander E, Portela-Gomes G, Grimelius L, Lundqvist G, Skoog V (1977 a) Enteroglucagon and substance P-like immunoreactivity in argentaffin and argyrophil rectal carcinoids. Virchows Arch B Cell Pathol 25: 117–124
Wilander E, Portela-Gomes G, Grimelius L, Westermark P (1977) Argentaffin and Argyrophil reactions of human gastrointestinal carcinoids. Gastroenterology 73: 733–736
Wilander E, Grimelius L, Portela-Gomes G, Lundqvist G, Skoog V, Westermark P (1979) Substance P and enteroglucagon-like immunoreactivity in argentaffin and argyrophil midgut carcinoid tumours. Scand J Gastroenterol [Suppl 53] 14: 19–25
Wilkin JK (1981) Flushing Reactions: Consequences and mechanisms. Ann Intern Med 95: 468–476
Williams ED, Sandler M (1963) The Classification of carcinoid tumours. Lancet 1: 238–239
Williams ED, Siebenmann RE, Sobin LH (1980) Histological typing of endocrine tumours. Internat histological classifications of tumours. No. 23, World Health Organization, Genf, pp 46–52
Wood WJ, Archer R, Schaeffer JW, Stephens C, Griffen WO (1970) Coexistence of regional enteritis and carcinoid tumor. Gastroenterology 59: 265–269
Woodtli W, Gemsenjager E, Heitz Ph U, Gloor F, Rosch W, Bosseckert H (1982) Endokrine Tumoren ( APUDome) des Duodenums - Eine kooperative Studie. Schweiz Rundschau Med 71: 1045–1053
Yang D, Garner R, Beetham WP (1978) Dermatomyositis, myocardial involvement, and carcinoid syndrome. JAMA 239: 1067–1068
Zakariai YM, Quan SHQ, Hajdu SI (1975) Carcinoid tumors of the gastrointestinal tract. Cancer 35: 588–591
Zarafonetis CJD, Lorber SH, Hanson SM (1958) Association of functioning carcinoid syndrome and scleroderma. Am J Med Sci 236: 1–14
Zeegen R, Rothwell-Jackson R, Sundler M (1969) Massive hepatic resection for the carcinoid syndrome. Gut 10: 617–622
Zuluaga U (1979) Karzinoid and Karzinoidsyndrom. Rita G Fischer, Frankfurt
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Feurle, G.E., Helmstädter, V. (1983). Endokrine Tumoren des Dünndarms. In: Bommer, W., et al. Dünndarm B. Handbuch der inneren Medizin, vol 3 / 3 / B. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68897-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-68897-3_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68898-0
Online ISBN: 978-3-642-68897-3
eBook Packages: Springer Book Archive